Robert Gerstl

Array ( [id] => 1495430 [patent_doc_number] => 06403572 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Producing Z-isomer of hydrogen bromide salt of 2-aminothiazole derivative' [patent_app_type] => B1 [patent_app_number] => 09/991728 [patent_app_country] => US [patent_app_date] => 2001-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11561 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403572.pdf [firstpage_image] =>[orig_patent_app_number] => 09991728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5815446 [patent_doc_number] => 20020040149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-04 [patent_title] => 'EP4 receptor selective agonists in the treatment of osteoporosis' [patent_app_type] => new [patent_app_number] => 09/991585 [patent_app_country] => US [patent_app_date] => 2001-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18494 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20020040149.pdf [firstpage_image] =>[orig_patent_app_number] => 09991585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1316158 [patent_doc_number] => 06605255 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-08-12 [patent_title] => 'Repinotan kit' [patent_app_type] => B2 [patent_app_number] => 09/991222 [patent_app_country] => US [patent_app_date] => 2001-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4506 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/605/06605255.pdf [firstpage_image] =>[orig_patent_app_number] => 09991222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6545663 [patent_doc_number] => 20020137740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Aminothiazole derivatives, process for preparing them and pharmaceutical compositions containing them' [patent_app_type] => new [patent_app_number] => 09/998949 [patent_app_country] => US [patent_app_date] => 2001-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12873 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137740.pdf [firstpage_image] =>[orig_patent_app_number] => 09998949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1369713 [patent_doc_number] => 06566384 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-20 [patent_title] => 'Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity' [patent_app_type] => B1 [patent_app_number] => 10/011031 [patent_app_country] => US [patent_app_date] => 2001-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28738 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 253 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566384.pdf [firstpage_image] =>[orig_patent_app_number] => 10011031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6292476 [patent_doc_number] => 20020055640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'Process for the production of dithiazolyl disulfides' [patent_app_type] => new [patent_app_number] => 10/011453 [patent_app_country] => US [patent_app_date] => 2001-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3569 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20020055640.pdf [firstpage_image] =>[orig_patent_app_number] => 10011453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6210245 [patent_doc_number] => 20020072616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-13 [patent_title] => '3-azabicyclo[3.1.0]hexane derivatives useful in therapy' [patent_app_type] => new [patent_app_number] => 10/016745 [patent_app_country] => US [patent_app_date] => 2001-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74316 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20020072616.pdf [firstpage_image] =>[orig_patent_app_number] => 10016745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1325676 [patent_doc_number] => 06602900 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-08-05 [patent_title] => 'Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents' [patent_app_type] => B2 [patent_app_number] => 10/021485 [patent_app_country] => US [patent_app_date] => 2001-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11865 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 197 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/602/06602900.pdf [firstpage_image] =>[orig_patent_app_number] => 10021485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1093553 [patent_doc_number] => 06825355 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-30 [patent_title] => 'Benzothiazole protein trosine kinase inhibitors' [patent_app_type] => B2 [patent_app_number] => 10/032609 [patent_app_country] => US [patent_app_date] => 2001-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24886 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 2909 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/825/06825355.pdf [firstpage_image] =>[orig_patent_app_number] => 10032609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1321086 [patent_doc_number] => RE038188 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2003-07-15 [patent_title] => 'Ethylene derivatives and pesticides containing said derivatives' [patent_app_type] => E1 [patent_app_number] => 09/983477 [patent_app_country] => US [patent_app_date] => 2001-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 79601 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 2098 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/038/RE038188.pdf [firstpage_image] =>[orig_patent_app_number] => 09983477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5788589 [patent_doc_number] => 20020160992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts' [patent_app_type] => new [patent_app_number] => 10/003514 [patent_app_country] => US [patent_app_date] => 2001-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7508 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160992.pdf [firstpage_image] =>[orig_patent_app_number] => 10003514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6658658 [patent_doc_number] => 20030078426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Amine derivative compounds' [patent_app_type] => new [patent_app_number] => 09/971634 [patent_app_country] => US [patent_app_date] => 2001-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57553 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20030078426.pdf [firstpage_image] =>[orig_patent_app_number] => 09971634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6529493 [patent_doc_number] => 20020136697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => '4-hydroxyisothiazole compounds' [patent_app_type] => new [patent_app_number] => 09/969738 [patent_app_country] => US [patent_app_date] => 2001-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5904 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20020136697.pdf [firstpage_image] =>[orig_patent_app_number] => 09969738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6408780 [patent_doc_number] => 20020037915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Compounds and compositons for treating C1s-mediated diseases and conditions' [patent_app_type] => new [patent_app_number] => 09/962304 [patent_app_country] => US [patent_app_date] => 2001-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 108255 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20020037915.pdf [firstpage_image] =>[orig_patent_app_number] => 09962304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5788735 [patent_doc_number] => 20020161019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Substituted azole derivatives as inhibitors of corticotropin releasing factor' [patent_app_type] => new [patent_app_number] => 09/954137 [patent_app_country] => US [patent_app_date] => 2001-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14644 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20020161019.pdf [firstpage_image] =>[orig_patent_app_number] => 09954137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1478966 [patent_doc_number] => 06451858 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-09-17 [patent_title] => 'Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives' [patent_app_type] => B2 [patent_app_number] => 09/950957 [patent_app_country] => US [patent_app_date] => 2001-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13604 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451858.pdf [firstpage_image] =>[orig_patent_app_number] => 09950957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6409990 [patent_doc_number] => 20020038034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Intermediates for the preparation of 2-imidazolin-5-ones' [patent_app_type] => new [patent_app_number] => 09/945675 [patent_app_country] => US [patent_app_date] => 2001-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2526 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20020038034.pdf [firstpage_image] =>[orig_patent_app_number] => 09945675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1343245 [patent_doc_number] => 06586463 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-01 [patent_title] => 'C16 unsaturated FP-selective prostaglandins analogs' [patent_app_type] => B2 [patent_app_number] => 09/946021 [patent_app_country] => US [patent_app_date] => 2001-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8320 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586463.pdf [firstpage_image] =>[orig_patent_app_number] => 09946021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6624558 [patent_doc_number] => 20020016327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-07 [patent_title] => 'Compounds and methods of use for treatment of neurogenic inflammation' [patent_app_type] => new [patent_app_number] => 09/944881 [patent_app_country] => US [patent_app_date] => 2001-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5488 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20020016327.pdf [firstpage_image] =>[orig_patent_app_number] => 09944881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1478975 [patent_doc_number] => 06451859 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'C16 unsaturated FP-selective prostaglandins analogs' [patent_app_type] => B1 [patent_app_number] => 09/914531 [patent_app_country] => US [patent_app_date] => 2001-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10889 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451859.pdf [firstpage_image] =>[orig_patent_app_number] => 09914531 [rel_patent_id] =>[rel_patent_doc_number] =>)